Bionovate Technologies Stock Forward View
| BIIO Stock | USD 0.0001 0.00 0.00% |
Bionovate Stock outlook is based on your current time horizon. Although Bionovate Technologies' naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Bionovate Technologies' systematic risk associated with finding meaningful patterns of Bionovate Technologies fundamentals over time.
As of today the relative strength index (rsi) of Bionovate Technologies' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Bionovate Technologies hype-based prediction, you can estimate the value of Bionovate Technologies Corp from the perspective of Bionovate Technologies response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Bionovate Technologies Corp on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0 and the sum of the absolute errors of 0. Bionovate Technologies after-hype prediction price | USD 1.0E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Bionovate | Build AI portfolio with Bionovate Stock |
Bionovate Technologies Additional Predictive Modules
Most predictive techniques to examine Bionovate price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bionovate using various technical indicators. When you analyze Bionovate charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Bionovate Technologies Cash Forecast
Forecasting financial indicators like cash flow involves analysts applying various statistical methods, techniques, and algorithms. These tools reveal hidden trends within the Bionovate Technologies' financial statements to estimate their effects on upcoming price movements.
Cash | First Reported 2010-12-31 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 22.6 K |
Bionovate Technologies Naive Prediction Price Forecast For the 14th of February 2026
Given 90 days horizon, the Naive Prediction forecasted value of Bionovate Technologies Corp on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0, mean absolute percentage error of 0, and the sum of the absolute errors of 0.Please note that although there have been many attempts to predict Bionovate Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Bionovate Technologies' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Bionovate Technologies Stock Forecast Pattern
| Backtest Bionovate Technologies | Bionovate Technologies Price Prediction | Research Analysis |
Bionovate Technologies Forecasted Value
In the context of forecasting Bionovate Technologies' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Bionovate Technologies' downside and upside margins for the forecasting period are 0.0001 and 0.0001, respectively. We have considered Bionovate Technologies' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Bionovate Technologies stock data series using in forecasting. Note that when a statistical model is used to represent Bionovate Technologies stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 30.385 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.0 |
| SAE | Sum of the absolute errors | 0.0 |
Predictive Modules for Bionovate Technologies
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bionovate Technologies. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Bionovate Technologies After-Hype Price Density Analysis
As far as predicting the price of Bionovate Technologies at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bionovate Technologies or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Bionovate Technologies, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Bionovate Technologies Estimiated After-Hype Price Volatility
In the context of predicting Bionovate Technologies' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bionovate Technologies' historical news coverage. Bionovate Technologies' after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered Bionovate Technologies' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Bionovate Technologies is very steady at this time. Analysis and calculation of next after-hype price of Bionovate Technologies is based on 3 months time horizon.
Bionovate Technologies Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Bionovate Technologies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bionovate Technologies backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bionovate Technologies, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 2 Events / Month | 4 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.0001 | 0.0001 | 0.00 |
|
Bionovate Technologies Hype Timeline
Bionovate Technologies is currently traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Bionovate is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Bionovate Technologies is about 0.0%, with the expected price after the next announcement by competition of 0.00. About 49.0% of the company shares are held by company insiders. The company last dividend was issued on the 9th of January 2020. Bionovate Technologies had 1:100 split on the 9th of January 2020. Given the investment horizon of 90 days the next forecasted press release will be in a few days. Check out Historical Fundamental Analysis of Bionovate Technologies to cross-verify your projections.Bionovate Technologies Related Hype Analysis
Having access to credible news sources related to Bionovate Technologies' direct competition is more important than ever and may enhance your ability to predict Bionovate Technologies' future price movements. Getting to know how Bionovate Technologies' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bionovate Technologies may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| IINN | Inspira Technologies Oxy | 0.07 | 9 per month | 0.00 | (0.18) | 6.86 | (6.96) | 15.99 | |
| PTHL | Pheton Holdings Ltd | 0.05 | 6 per month | 6.77 | 0.02 | 6.56 | (9.84) | 136.77 | |
| BMRA | Biomerica | 0.05 | 8 per month | 0.00 | (0.06) | 4.37 | (4.98) | 18.44 | |
| HSCS | Heart Test Laboratories | (0.18) | 9 per month | 4.84 | 0.06 | 11.07 | (7.86) | 26.18 | |
| SSKN | STRATA Skin Sciences | (0.07) | 7 per month | 0.00 | (0.16) | 7.56 | (7.56) | 18.95 | |
| APVO | Aptevo Therapeutics | 0.14 | 8 per month | 0.00 | (0.29) | 7.81 | (10.34) | 43.37 | |
| ADVB | Advanced Biomed Common | 0.01 | 4 per month | 0.00 | (0.14) | 8.11 | (9.68) | 28.22 | |
| BNR | Burning Rock Biotech | 0.03 | 7 per month | 6.90 | 0.18 | 18.91 | (13.63) | 50.29 |
Other Forecasting Options for Bionovate Technologies
For every potential investor in Bionovate, whether a beginner or expert, Bionovate Technologies' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Bionovate Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Bionovate. Basic forecasting techniques help filter out the noise by identifying Bionovate Technologies' price trends.Bionovate Technologies Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bionovate Technologies stock to make a market-neutral strategy. Peer analysis of Bionovate Technologies could also be used in its relative valuation, which is a method of valuing Bionovate Technologies by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Bionovate Technologies Market Strength Events
Market strength indicators help investors to evaluate how Bionovate Technologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bionovate Technologies shares will generate the highest return on investment. By undertsting and applying Bionovate Technologies stock market strength indicators, traders can identify Bionovate Technologies Corp entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
Story Coverage note for Bionovate Technologies
The number of cover stories for Bionovate Technologies depends on current market conditions and Bionovate Technologies' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bionovate Technologies is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bionovate Technologies' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Check out Historical Fundamental Analysis of Bionovate Technologies to cross-verify your projections. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Will Health Care Equipment & Supplies sector continue expanding? Could Bionovate diversify its offerings? Factors like these will boost the valuation of Bionovate Technologies. Projected growth potential of Bionovate fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Bionovate Technologies data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Bionovate Technologies's market price often diverges from its book value, the accounting figure shown on Bionovate's balance sheet. Smart investors calculate Bionovate Technologies' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Bionovate Technologies' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Bionovate Technologies' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bionovate Technologies should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Bionovate Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.